Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Zhejiang Cancer Hospital

5 clinical trials · 5 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Zhejiang Cancer Hospital

RECRUITINGPhase 4NCT05148767

UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer

To explore whether the application of irinotecan under the guidance of UGT1A1 gene in neoadjuvant chemotherapy and radiotherapy for locally advanced rectal cancer could improve...

Sponsor: Zhejiang Cancer HospitalEnrolling: 6061 location
Rectal Cancer Stage III
RECRUITINGNCT06711432

Different Intraoperative Blood Pressure Management on Postoperative Cognitive Function in Tumor Patients(PRECISION)

This is a randomized controlled study to explore whether perioperative blood pressure management with different strategies can reduce the incidence of delirium and postoperative...

Sponsor: Zhejiang Cancer HospitalEnrolling: 2141 location
TumorStroke
RECRUITINGPhase 2NCT05920863

Lenvatinib Combined with Tislelizumab and TACE Applied As Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA...

This is a monocenter, single-arm, open-label study to evaluate the efficacy and safety of Lenvatinib combined with Tislelizumab and TACE applied as neoadjuvant regimen for the...

Sponsor: Zhejiang Cancer HospitalEnrolling: 351 location
Hepatocellular CarcinomaLenvatinibTislelizumab+3
RECRUITINGNCT07067983

Clinical Evaluation of GRAPE Model for Gastric Cancer Screening

A Prospective Study Evaluating the Performance of the GRAPE Model in Gastric Cancer Screening and Its Detection Rates Across Different Disease Stages

Sponsor: Zhejiang Cancer HospitalEnrolling: 10000001 location
Gastric Cancer
RECRUITINGPhase 2NCT06509568

Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell...

Based on our previous single-arm Phase Ib study (CRIS trial, NCT06303583), we observed that neoadjuvant chemoradiotherapy followed by immunotherapy (nCRIT) significantly increased...

Sponsor: Zhejiang Cancer HospitalEnrolling: 921 location
Esophageal Squamous Cell Carcinoma